Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
Clinical trial NCT04886531 · RECRUITING
Trial details
- NCT number
- NCT04886531
- Sponsor
- Ruth O'Regan
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-21
- Primary completion
- 2026-06-22
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.